期刊文献+

非酒精性血清丙氨酸氨基转移酶升高与代谢参数的相关性分析 被引量:4

Relationship between increased serum activity of alanine aminotransferase and metabolic parameters in non-alcoholic population
原文传递
导出
摘要 目的分析中国北方汉族人群非酒精性血清ALT水平升高与各代谢参数的相关性。方法将5351名在清华大学玉泉医院体检的受试者根据ALT升高与否(940U/L)分为两组,比较两组间各代谢组分的差异。结果体重指数(BMI)、收缩压、舒张压、甘油三酯、总胆固醇、高密度脂蛋白胆固醇(HDL—C)、低密度脂蛋白胆固醇(LDL—C)及空腹血糖(FBG)水平在ALT升高组与对照组问差异有统计学意义。男性ALT升高与舒张压有关,而女性与收缩压有关。logistic回归分析结果表明,ALT升高与男性、BMI、甘油三酯、总胆固醇和FBG水平升高、LDL—C水平降低和年龄较低有关。结论在中国北方汉族人群中,肥胖、高血压、高血脂、高血糖等代谢紊乱与非酒精性ALT升高有关。 Objective The aim of this study is to identify association between increased serum activity of alanine aminotransferase (ALT) and metabolic parameters in non-alcoholic population of north China. Methods A total of 5351 subjects who came to visit Yuquan Hospital of Tsinghua University for health examinations during May to December 2007 were divided into two groups based on their serum ALT activities, one with equal to or more than 40 U/L and the other with less than 40. Anthropometrie data, blood pressure, serum ALT, serum levels of tfiglyeeride (TG), total cholesterol (TC), high-dense lipoprotein-cholesterol (HDL-C), low-dense lipoprotein-eholesterol (LDL-C) and fasting blood glucose (FBG) were measured for all of them. Results Body mass index ( BMI), systolic blood pressure ( SBP), diastolic blood pressure ( DBP), TG, TC, HDL-C, LDL-C and FBG were significantly different between the two groups. BMI, TG, TC, HDL-C, LDL-C and FBG all associated with increased ALT both in males and females. DBP associated with increased ALT in males and SBP with it in females. Logistic regression analysis showed that male, younger age, raised BMI, TG, TC, FBG and reduced HDL-C were strongly associated with increased serum ALT. Conclusions Results showed that metabolic disturbance such as obesity, hypertension, dyslipidemia, hyperglycemia, and so on associated with increased ALT in nonalcoholic population of north China.
出处 《中华全科医师杂志》 2008年第11期748-750,共3页 Chinese Journal of General Practitioners
关键词 丙氨酸转氨酶 脂类代谢 高血压 超重 碳水化合物代谢 Alanine transaminase Lipid metabolism Hypertension Overweight Carbohydrate metabolism
  • 相关文献

参考文献11

  • 1Angulo P. Nonalcoholic fatty liver disease. N Engl J Med, 2002, 346 : 1221-1231.
  • 2Hsiao TJ, Chen JC, Wang JD. Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients. Int J Obes Relat Metab Disord, 2004, 28 : 167-172.
  • 3Suzuki A, Angulo P, Lymp J, et al. Chronological development of elevated aminolransferases in a nonalcoholic population. Hepatology, 2005, 41: 64-71.
  • 4Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology, 2005, 42: d4-52.
  • 5Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 6Hanley A J, Wagenknecht LE, Festa A, et al. Alanine amino transferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care, 2007, 30 : 1819-1827.
  • 7Bugianesi F, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology, 2005, 42: 987- 1000.
  • 8Park SH, Kim BI, Yun JW, et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol, 2004, 19: 694-698.
  • 9Kerner A, Avizohar O, Sella R, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol, 2005, 25: 193-197.
  • 10Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 2001, 50: 1844- 1850.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1512

同被引文献30

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部